loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Drug Master Files (JDMF) for Cilastatin Sodium Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ACS DOBFAR S. p. A. (1)

02 JW Pharmaceutical Corporation (1)

filter

01 Cilastatin Sodium (1)

02 Cilastatin sodium (1)

filter

01 Italy (1)

02 Blank (1)

URL Supplier Web Content
304MF10136
Viale Addetta, 4/12, 20067 Tribiano...
2022-10-05
2022-10-05
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Country
Digital Content Digital Content
URL Supplier Web Content
219MF10001
2477, Nambusunhwan-ro Seocho-gu, Se...
2012-05-11
2007-01-18
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 81129-83-1 / Cilastatin Sodium API manufacturers, exporters & distributors?

Cilastatin Sodium manufacturers, exporters & distributors 1

41

PharmaCompass offers a list of Cilastatin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cilastatin Sodium manufacturer or Cilastatin Sodium supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cilastatin Sodium manufacturer or Cilastatin Sodium supplier.

PharmaCompass also assists you with knowing the Cilastatin Sodium API Price utilized in the formulation of products. Cilastatin Sodium API Price is not always fixed or binding as the Cilastatin Sodium Price is obtained through a variety of data sources. The Cilastatin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cilastatin Sodium

Synonyms

81129-83-1, Cilastatin sodium salt, Cilastatin na, Mls001401364, Sodium;(z)-7-[(2r)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1s)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate, Mk-791

Cas Number

81129-83-1

About Cilastatin Sodium

A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.

Cilastatin Sodium Manufacturers

A Cilastatin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cilastatin Sodium, including repackagers and relabelers. The FDA regulates Cilastatin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cilastatin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cilastatin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cilastatin Sodium Suppliers

A Cilastatin Sodium supplier is an individual or a company that provides Cilastatin Sodium active pharmaceutical ingredient (API) or Cilastatin Sodium finished formulations upon request. The Cilastatin Sodium suppliers may include Cilastatin Sodium API manufacturers, exporters, distributors and traders.

click here to find a list of Cilastatin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cilastatin Sodium JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Cilastatin Sodium Drug Master File in Japan (Cilastatin Sodium JDMF) empowers Cilastatin Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Cilastatin Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Cilastatin Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Cilastatin Sodium suppliers with JDMF on PharmaCompass.

Cilastatin Sodium Manufacturers | Traders | Suppliers

Cilastatin Sodium Manufacturers, Traders, Suppliers 1
95

We have 2 companies offering Cilastatin Sodium

Get in contact with the supplier of your choice:

  1. ACS DOBFAR SPA
  2. Choongwae Pharma Corporation
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY